Equitable Trust CO Astrazeneca PLC Transaction History
Equitable Trust CO
- $1.93 Billion
- Q2 2025
A detailed history of Equitable Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Equitable Trust CO holds 35,909 shares of AZN stock, worth $2.75 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
35,909
Previous 55,399
35.18%
Holding current value
$2.75 Million
Previous $4.07 Million
38.37%
% of portfolio
0.13%
Previous 0.23%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.37 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.11 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.73 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.44 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.4 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $237B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...